LAERA, LETIZIA
LAERA, LETIZIA
Dipartimento di Biotecnologie Mediche
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer
2015-01-01 Roviello, Giandomenico; Francini, Edoardo; Perrella, Armando; Laera, Letizia; Mazzei, MARIA ANTONIETTA; Guerrini, Susanna; Petrioli, Roberto
Cisplatin, etoposide, and bevacizumab regimen followed by oral etoposide and bevacizumab maintenance treatment in patients with extensive-stage small cell lung cancer: A single-institution experience
2015-01-01 Petrioli, R.; Roviello, G.; Laera, L.; Luzzi, L.; Paladini, P.; Ghiribelli, C.; Voltolini, L.; Martellucci, I.; Bianco, V.; Francini, E.
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer
2015-01-01 Roviello, Giandomenico; Francini, Edoardo; Perrella, Armando; Laera, Letizia; Mazzei, MARIA ANTONIETTA; Guerrini, Susanna; Roviello, Franco; Marrelli, Daniele; Petrioli, Roberto
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
2015-01-01 Petrioli, Roberto; Roviello, Giandomenico; Fiaschi, ANNA IDA; Laera, Letizia; Marrelli, Daniele; Roviello, Franco; Francini, Edoardo
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer.
2015-01-01 Petrioli, Roberto; Roviello, Giandomenico; Fiaschi, Ai; Laera, Letizia; Bianco, V; Ponchietti, Roberto; Barbanti, G; Francini, E.
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer
2015-01-01 Petrioli, Roberto; Roviello, Giandomenico; Fiaschi, ANNA IDA; Laera, Letizia; Miano, SALVATORA TINDARA; Marrelli, Daniele; Roviello, Franco; Bianco, Vincenzo; Francini, Edoardo
Metabolomics as predictive biomarker of response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
2020-01-01 Laera, L
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate
2015-01-01 Petrioli, Roberto; Francini, E; Ponchietti, Roberto; Roviello, Giandomenico; Laera, Letizia; Fiaschi, ANNA IDA
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience
2015-01-01 Petrioli, Roberto; Francini, Edoardo; Roviello, Franco; Marrelli, Daniele; Fiaschi, ANNA IDA; Laera, Letizia; Rossi, Giulia; Bianco, V; Brozzetti, S; Roviello, Giandomenico
Switch maintenance treatment with oral vinorelbine and bevacizumab after induction chemotherapy with cisplatin, gemcitabine and bevacizumab in patients with advanced non-squamous non-small cell lung cancer: a phase II study
2015-01-01 Petrioli, R.; Francini, E.; Fiaschi, A. I.; Laera, L.; Luzzi, L.; Paladini, P.; Ghiribelli, C.; Voltolini, L.; Bianco, V.; Roviello, G.
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience.
2015-01-01 Francini, E; Fiaschi, Ai; Petrioli, Roberto; Laera, Letizia; Bianco, V; Ponchietti, Roberto; Roviello, Giandomenico
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status
2015-01-01 Petrioli, Roberto; Francini, Edoardo; Roviello, Franco; Marrelli, Daniele; Miano, SALVATORA TINDARA; Fiaschi, ANNA IDA; Laera, Letizia; Bellini, MARCO ANTONIO; Roviello, Giandomenico